129784668196772500_330Littaye pharmaceuticals IPO storm trapped quality products have been checked is not eligible
On March 19, the SFC website disclosed the Guangdong Li Tai pharmaceutical company limited (hereinafter referred to as "Li Tai pharmaceutical") the initial prospectus. Prospectus shows that Li Tai pharmaceuticals the IPO plans to issue 29.3388 million shares, after the release of total shares 117.3388 million shares, however, exposed in the prospectus of the company product quality be liable to fail many times to make itCast a shadow over the road to IPO. Checked out gelitai Pharmaceuticals has been mainly engaged in the development, production and sales of amino acid infusion, leading products include ammonia Plaud, Andre Pirro, 18AA series of compound amino acid etc. During the reporting period, main business revenue proportion of amino acid infusion, 72.3%, 83.75%, respectively, are operatingIncome mainly relies on. Prospectus 1-1-169 pages, company since its inception, there have been four pharmaceutical supervision and management quality notification is not eligible, ineligible items are visible, such as foreign bodies, translucent. The gold stock journalist access to its historical data found that Li Tai pharmaceuticals relating to defective items not only involves the injection of sodium chloride, glucose productionAnd even amino acids injection there are also its main product quality "bad record". In 2006, published by the food and drug administration in Yunnan province is not in the list of eligible drugs in the third quarter, and Thai pharmaceutical production batch of 0503242 in compound amino acid injection is not eligible
tera power leveling, ineligible item is a product of "character, and transparency". First half of 2008, Jiangxi province qualityBulletin shows that Li Tai pharmaceutical production batch of 07101536 glucose and sodium chloride injection failed to pass the examination. According to the test result
tera gold, unqualified items as "foreign bodies". In 2009, the product quality bulletin display in the second quarter, Guangdong Province, Li Tai pharmaceutical production batch of 08030542 sodium chloride injection being detected as failed, product is notProject is that "foreign bodies", the company was subjected to penalties in Puning city, food and drug administration. In 2010, Lee Thai pharmaceutical production batch number is 0901141 in compound amino acid injection, disqualification in Jiangxi province was again detected, unqualified items as "foreign bodies". Test results are differences are interesting, different placesGovernment regulators on the test results are not the same. Littaye pharmaceutical 2006 substandard drugs seized in Yunnan, Jieyang city, Guangdong Province food and drug administration review of qualified, and that character and transparency do not meet the requirements, may be because the long distance transport and storage conditions caused by inappropriate; the first half of 2008 were checking out substandard products in Jiangxi province, Guangdong ProvinceNing city are considered by the food and drug administration, product review of qualified, visible foreign bodies may be long during transport or handling bottles accident impact extrusion, causing visible foreign bodies do not meet the requirements; 2010 product in Jiangxi province was once again identified problems, food and drug administration in May 2010 in Jieyang verification, product review of qualified, does not match the visible foreign bodiesProvisions may be caused by inappropriate storage conditions. It is to be noted that, Li Tai pharmaceuticals in Puning city, Guangdong Province (counties, belong to the jurisdiction of Jieyang City) in South Mt. Town industrial zone. Four drug supervision and Management Department of the company quality communications fail
tera gold, three provinces were identified of which quality is not qualified, local authorities review appears qualified. Only 2009-CantonEastern Province was found defective product, Puning, food and drug administration of punishment and penalties amounting to $ 22,469. As a pharmaceutical company, the importance of product quality speaks for itself. Littaye pharmaceutical product quality have no bruising? Reporters of the gold stock would continue to focus.
Others:
没有评论:
发表评论